2025
article
OpenAlex
Marco Troisi, Monica Fabbrini, Samuele Stazzoni, Viola Viviani et autres
Gonococcus, a bacterium resistant to most antibiotics, causes more than 80 million cases of gonorrhea annually and is considered a high-priority pathogen by the World Health Organization. Recently, vaccine development prospects were boosted by reports that licensed meningococcus serogroup B (MenB) vaccines …
it, ar, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Giacomo Vezzani, Viola Viviani, Martina Audagnotto, Alessandro Rossi et autres
Introduction: The 4CMenB vaccine licensed against serogroup B Neisseria meningitidis (MenB) contains three recombinant proteins and Outer Membrane Vesicles (OMV) from a New Zealand epidemic strain. The protective response mediated on differentmeningococcal strains has been historically ascribed to one of the four …
it, ar
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Daniele Veggi, Chelsy C. Chesterman, Laura Santini, Ying Huang et autres
serogroup B (MenB) is the leading cause of such disease in developed countries. Two vaccines, 4CMenB and MenB-fHbp, that protect against MenB are available and include one or two forms respectively of factor H binding protein (fHbp), a key protective antigen. Studies …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Gian Pietro Pietri, Sara Bertuzzi, Katarina Karničar, Luca Unione et autres
Meningococcal glycoconjugate vaccines sourced from capsular polysaccharides (CPSs) of pathogenic Neisseria meningitidis strains are well-established measures to prevent meningococcal disease. However, the exact structural factors responsible for antibody recognition are not known. CPSs of Neisseria meningitidis serogroups Y and W differ by …
hr, es, si
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Marco Troisi, Monica Fabbrini, Samuele Stazzoni, Viola Viviani et autres
ABSTRACT Gonococcus (Gc), a bacterium resistant to most antibiotics causing more than 80 million cases of gonorrhea annually, is a WHO high priority pathogen. Recently, vaccine development prospects were boosted by reports that licensed meningococcus serogroup B (MenB) vaccines provided partial protection …
it, gb
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Rita Cersosimo, Laura Santini
This essay is an account of the development and implementation of the ‘English Project’ at the University of Genoa, aimed at establishing a language standard at B1 level, assessing freshers, and providing a structured path if such proficiency is not met. The …
it
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Gian Pietro Pietri, Marta Tontini, Barbara Brogioni, Davide Oldrini et autres
Despite the considerable progress toward the eradication of meningococcal disease with the introduction of glycoconjugate vaccines, previously unremarkable serogroup X has emerged in recent years, recording several outbreaks throughout the African continent. Different serogroup X polysaccharide-based vaccines have been tested in preclinical …
hr, it, fr, es
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Laura Santini
Framed within the current knowledge age you-culture, textual you is first discussed as a philosophical and ethical address. A specific textual analysis follows to investigate a narrative mode that the existing narratological taxonomy finds it hard to accommodate, while authors, aiming at …
Accès ouvert
2020
article
OpenAlex
Marzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, Maria Moriondo et autres
analysis, we assessed bactericidal activity of antibodies in sera from children primed with MenACWY-CRM or MenC-CRM conjugate vaccines and receiving a MenACWY-CRM booster dose against 5 meningococcal C (MenC) strains isolated from IMD cases. Sera collected from 90 infants/toddlers who participated in …
it, il, nl
(code pays fourni par la source)
2020
article
OpenAlex
Alessia Biolchi, Sara Tomei, Laura Santini, Rita La Gaetana et autres
BACKGROUND: Neisseria meningitidis serogroup B (MenB) causes most meningitis outbreaks worldwide. We evaluated the ability of the 4-component MenB vaccine (4CMenB) to induce bactericidal activity against outbreak strains in adolescents. METHODS: Individual sera from 20 United States and 23 Chilean adolescents who …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Daniele Veggi, Federica Bianchi, Laura Santini, Paola Lo Surdo et autres
Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB are now available (i.e. 4CMenB and MenB-fHbp). Both vaccines …
it, us
(code pays fourni par la source)
Accès ouvert
2020
conference-abstract
OpenAlex
Alessia Biolchi, Sara Tomei, Laura Santini, Rita La Gaetana et autres
Abstract Background Meningococcal outbreaks have often been associated with N. meningitidis serogroup B (MenB) in high-income countries. We examined whether antibodies elicited by the 4-component MenB vaccine (4CMenB) in adolescents could induce complement-mediated bacterial killing of a panel of 14 genetically diverse …
it
(code pays fourni par la source)